Sharing tissue factor a winning strategy in tumorigenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 11, 2008, Pages 1885-1886

  Rao, Vijaya Mohan ^a   Pendurthi, Usha R ^a  

^a UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN; ANTINEOPLASTIC AGENT;

BLOOD CLOTTING; CARCINOGENESIS; CARCINOMA; EDITORIAL; EMBRYONIC STEM CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; CANCER STEM CELL; CELL SURVIVAL; ENDOTHELIUM CELL; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NOTE; PATHOLOGY; SECRETORY VESICLE; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; SECRETORY VESICLES; THROMBOPLASTIN;

EID: 55449131960     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.176149     Document Type: Editorial

References (14)

1. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's Syndrome revisited. Blood. 1983;62:14-31.
2. Rao LVM. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 1992;11:249-266.
3. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 2003;124:58S-68S.
4. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol. 1996;3:379-384.
5. Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization and cancer coagulopathy. Semin Thromb Hemost. 2006;32:54-70.
6. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol. 2005;25:1545-1550.
7. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, Felding-habermann B, Takada Y, Mueller BM, Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood. 2008;111:190-199.
8. Toomey JR, Kratzer KE, Lasky NM, Broze GJ Jr. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA. 1997;94:6922-6926.
9. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Hu Z, Barney KA, Degen JL. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood. 2007;110:133-141.
10. Parry GC, Erlich JH, Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest. 1998;101:560-569.
11. Yu J, May L, Milsom C, Anderson GM, Weitz JI, Luyendyk JP, Broze G, Mackman N, Rak J. Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol. 2008;28:1975-1981.
12. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005;106:1604-1611.
13. Edwards RL, Rickles FR, Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med. 1981;98:917-928.
14. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nature Medicine. 1996;2:209-215.